Next |
home / stock / immu / immu message board
Subject | By | Source | When |
---|---|---|---|
Time to start loading for the long term | ilovestocks85 | investorshub | 10/24/2020 4:25:16 AM |
Piper boosts Gilead $GILD target to $95 from | BottomBounce | investorshub | 10/24/2020 1:13:53 AM |
NEWS -- Laboratory Testing of Brilacidin for COVID-19 | Here Today | investorshub | 09/15/2020 1:50:40 PM |
whytestocks: $IMMU News Article - Should You Buy Gilead Now That It's Acquiring Immunomedics? | whytestocks | investorshangout | 09/15/2020 12:00:48 PM |
JUST IN: $IMMU Should You Buy Gilead Now | whytestocks | investorshub | 09/15/2020 11:46:09 AM |
znewcar1: IMMU 97% v79,9M c83.65 f231M float increased from 231M preMH87.77 looking for S? | znewcar1 | investorshangout | 09/14/2020 8:12:26 PM |
Wheres Roland? | Ganz | investorshub | 09/14/2020 6:47:04 PM |
NEWS: $IMMU Nasdaq Set to Open Higher; NVIDIA, | whytestocks | investorshub | 09/14/2020 4:31:16 PM |
Breaking News: $IMMU Why Immunomedics Stock Is Screaming | whytestocks | investorshub | 09/14/2020 4:16:20 PM |
Vegas socks, I hate to say I told | Ganz | investorshub | 09/14/2020 3:30:30 PM |
Some to $IPIX for their 2 drugs Brilacidin | Here Today | investorshub | 09/14/2020 11:48:51 AM |
WOW JUST WOW.... $$$$87 | ison929 | investorshub | 09/14/2020 11:15:07 AM |
CONGRATS $IMMU LONGS | sushifishman | investorshub | 09/13/2020 9:38:27 PM |
$GILD acquires$ IMMU for $88/sh cash(~$21B) | DewDiligence | investorshub | 09/13/2020 7:49:55 PM |
Boo yah, bout time ! | Ganz | investorshub | 09/13/2020 7:46:24 PM |
My friend Scott has been talking to me | jim1234 | investorshub | 09/12/2020 8:23:18 PM |
O wow thats awesome now I wish I | BoilerRoom | investorshub | 09/12/2020 7:50:59 PM |
congratulations boileroom. Monday you https://www.wsj.com/articles/gilead-nears | jim1234 | investorshub | 09/12/2020 7:46:34 PM |
$IMMU been holding this stock for a long | BoilerRoom | investorshub | 09/12/2020 7:44:35 PM |
Looking good | Jaydixson1 | investorshub | 08/27/2020 1:04:28 AM |
News, Short Squeeze, Breakout and More Instantly...
Gilead Sciences (NASDAQ: GILD) can be both a hero and a goat, depending on your perspective as an investor. The stock price rose from $17 in July 2010 to $118 in July 2015, as the company introduced revolutionary HIV drugs and helped bring a cure for hepatitis C to market. Since the...
With huge investments being made in biotech thanks to the pandemic, there has been a renewed focus on biotech stocks. Here are three worth considering: Amgen (AMGN), Immunomedics (IMMU), Seattle Genetics (SGEN), and Genmab (GMAB). The biotechnology industry has rightfully received a huge ...
MORRIS PLAINS, N.J., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the Office of Orphan Products...